Literature DB >> 25017017

Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanoma.

David M Kaetzel1, Mary K Leonard, Gemma S Cook, Marian Novak, Stuart G Jarrett, Xiuwei Yang, Alexey M Belkin.   

Abstract

The NME1 gene represents the prototypical metastasis suppressor, whose expression inhibits cell motility and metastasis without impact on primary tumor growth in a number of different human cancers. This report outlines our recent efforts to define the molecular mechanisms through which NME1 both suppresses cell motility and promotes genomic integrity in the setting of human melanoma. Forced NME1 expression in a variety of melanoma-derived cell lines was shown to induce dynamic changes in cell morphology and reorganization of the actin cytoskeleton, with formation of a network of thick stress fibers and assembly of fibronectin fibrils at large focal adhesions. Moreover, NME1 expression results in adhesion reprogramming through an impact on integrin repertoire and focal adhesion dynamics. Having previously demonstrated that NME1 expression promotes repair of DNA damage induced by ultraviolet radiation (UVR) in both yeast and mammalian cells, probably via the nucleotide excision repair pathway, we have more recently demonstrated that NME1 is rapidly recruited to double-strand breaks. This preliminary result represents the first evidence of direct interactions between NME1 and DNA in the context of DNA repair and has set the stage for current efforts to probe its functional interactions with double-strand break repair pathways. Discussed herein are molecular models to explain the interactions of NME1 with such diverse cellular functions as cell motility and DNA repair, potentially through its nucleoside diphosphate kinase and 3'-5' exonuclease activities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25017017      PMCID: PMC4294989          DOI: 10.1007/s00210-014-1010-4

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

Review 1.  The 3' 5' exonucleases.

Authors:  Igor V Shevelev; Ulrich Hübscher
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

2.  Nucleoside diphosphokinase from human erythrocytes.

Authors:  R P Agarwal; B Robison; R E Parks
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

3.  In vivo cross-linking of nm23/nucleoside diphosphate kinase to the PDGF-A gene promoter.

Authors:  Laura Cervoni; Paola Pietrangeli; Silvia Chichiarelli; Fabio Altieri; Lorenza Egistelli; Carlo Turano; Ioan Lascu; Anna Giartosio
Journal:  Mol Biol Rep       Date:  2003-03       Impact factor: 2.316

4.  Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.

Authors:  A Leone; U Flatow; C R King; M A Sandeen; I M Margulies; L A Liotta; P S Steeg
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

Review 5.  Nm23/nucleoside diphosphate kinase in human cancers.

Authors:  M T Hartsough; P S Steeg
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

6.  Motility and adhesive properties of high- and low-metastatic murine neoplastic cells.

Authors:  T Volk; B Geiger; A Raz
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

7.  High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer.

Authors:  Fumihiro Oshita; Yoichi Kameda; Nobuyuki Hamanaka; Haruhiro Saito; Kouzo Yamada; Kazumasa Noda; Aki Mitsuda
Journal:  Am J Clin Oncol       Date:  2004-06       Impact factor: 2.339

8.  Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma.

Authors:  Johanna Nikkola; Pia Vihinen; Tatyana Vlaykova; Marjo Hahka-Kemppinen; Jyrki Heino; Seppo Pyrhönen
Journal:  Melanoma Res       Date:  2004-02       Impact factor: 3.599

9.  The metastasis suppressor NM23-H1 possesses 3'-5' exonuclease activity.

Authors:  Deqin Ma; Joseph R McCorkle; David M Kaetzel
Journal:  J Biol Chem       Date:  2004-02-11       Impact factor: 5.157

Review 10.  Inhibition of signal transduction by the nm23 metastasis suppressor: possible mechanisms.

Authors:  Massimiliano Salerno; Taoufik Ouatas; Diane Palmieri; Patricia S Steeg
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more
  7 in total

1.  Progress on Nme (NDP kinase/Nm23/Awd) gene family-related functions derived from animal model systems: studies on development, cardiovascular disease, and cancer metastasis exemplified.

Authors:  Tien Hsu; Patricia S Steeg; Massimo Zollo; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-01-15       Impact factor: 3.000

Review 2.  The actions of NME1/NDPK-A and NME2/NDPK-B as protein kinases.

Authors:  Paul V Attwood; Richmond Muimo
Journal:  Lab Invest       Date:  2017-12-04       Impact factor: 5.662

3.  NME1 Drives Expansion of Melanoma Cells with Enhanced Tumor Growth and Metastatic Properties.

Authors:  Ying Wang; M Kathryn Leonard; Devin E Snyder; Matthew L Fisher; Richard L Eckert; David M Kaetzel
Journal:  Mol Cancer Res       Date:  2019-05-23       Impact factor: 5.852

4.  Nm23-H1 is involved in the repair of ionizing radiation-induced DNA double-strand breaks in the A549 lung cancer cell line.

Authors:  Ya Sheng; Mingfang Xu; Chongyi Li; Yanli Xiong; Yi Yang; Xunjie Kuang; Dong Wang; Xueqin Yang
Journal:  BMC Cancer       Date:  2018-07-03       Impact factor: 4.430

5.  A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 is highly metastatic in vivo.

Authors:  Devin Snyder; Ying Wang; David M Kaetzel
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

6.  Metastasis Suppressor NME1 Modulates Choice of Double-Strand Break Repair Pathways in Melanoma Cells by Enhancing Alternative NHEJ while Inhibiting NHEJ and HR.

Authors:  Gemma Puts; Stuart Jarrett; Mary Leonard; Nicolette Matsangos; Devin Snyder; Ying Wang; Richard Vincent; Benjamin Portney; Rachel Abbotts; Lena McLaughlin; Michal Zalzman; Feyruz Rassool; David Kaetzel
Journal:  Int J Mol Sci       Date:  2020-08-17       Impact factor: 5.923

7.  Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients.

Authors:  M Kathryn Leonard; Gemma S Puts; Nidhi Pamidimukkala; Gautam Adhikary; Yili Xu; Eric Kwok; Yuxin Jin; Devin Snyder; Nicolette Matsangos; Marián Novak; Anup Mahurkar; Amol C Shetty; Radomir M Slominski; Edward C De Fabo; Frances P Noonan; Chi-Ping Day; Mohammed Rigi; Andrzej T Slominski; Michelle G Webb; David W Craig; Glenn Merlino; Richard L Eckert; John D Carpten; Zarko Manojlovic; David M Kaetzel
Journal:  Oncogene       Date:  2021-08-25       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.